MorphoSys Establishes ADR Level One Program in USA
News Jan 11, 2006
Morphosys AG has announced the launch of a sponsored ADR (American Depository Receipt) Program Level I in order to support broadening the Company's US investor base.
The trading symbol for MorphoSys's ADR is MPSYY and its CUSIP number is 617760103.
Each MorphoSys ADR represents one MorphoSys ordinary share as traded on the Frankfurt Stock Exchange.
MorphoSys has appointed The Bank of New York as the depositary bank for its ADR Program.
"The launch of our ADR Program is intended to increase access to the U.S. capital markets, and enhance the trading options for existing and potential new investors," commented Dave Lemus, Chief Financial Officer of MorphoSys.
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018